Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ResMed.
RELATED STOCKHEAD STORIES
News
What ASX investors should look for in a COVID-19 earnings season
Experts
Scopo’s powerplays: Strap yourselves in for some M&A
News
‘Dividend recession’ heading for the Australian market
Health & Biotech
COVID-19 adds $9bn to top four ASX health stocks
News
Kick Back: The 10 biggest stories you might have missed on Stockhead this week
Health & Biotech
Greens push for permanent telehealth funding
Health & Biotech
The healthcare winners and losers after COVID-19, and what comes next
Health & Biotech
We’re still here: investors keen on health despite market shun
Experts
Scopo’s health powerplays: Markets be crazy, buy the dip
Experts
ScoPo’s health powerplays: The transition to greatest
Health & Biotech
Dr Boreham’s Crucible: A simpler device gives Atomo the upper hand in blood-based diagnostics
Experts
ScoPo’s health powerplays: Cap raises goin’ crazy
Health & Biotech
Check up: Is anyone making non-COVID-19 money these days? Actually, yes
News
This is what being on a ‘war footing’ against COVID-19 looks like
Health & Biotech
Dr Boreham’s Crucible: Why CSL is the poster child for most junior drug developers
Health & Biotech
Health: Oventus isn’t sleeping on the job because it’s making too much money
Health & Biotech
